Polatuzumab vedotin

Drug
Thing
Polatuzumab vedotin is an antibody-drug conjugate or ADC designed for the treatment of cancer. The investigational drug, being developed by Genentech/Roche, contains a humanized monoclonal antibody targeting CD79b conjugated to the synthetic dolastatin 10 analog microtubule-disrupting monomethyl auristatin E through engineered cysteines via a protease-cleavable peptide linker.
Polatuzumab vedotin
Definition
Polatuzumab vedotin is an antibody-drug conjugate or ADC designed for the treatment of cancer. The investigational drug, being developed by Genentech/Roche, contains a humanized monoclonal antibody targeting CD79b conjugated to the synthetic dolastatin 10 analog microtubule-disrupting monomethyl auristatin E through engineered cysteines via a protease-cleavable peptide linker.
Polatuzumab vedotin
Polatuzumab vedotin
Polatuzumab vedotin is an antibody-drug conjugate or ADC designed for the treatment of cancer. The investigational drug, being developed by Genentech/Roche, contains a humanized monoclonal antibody targeting CD79b conjugated to the synthetic dolastatin 10 analog microtubule-disrupting monomethyl auristatin E through engineered cysteines via a protease-cleavable peptide linker.
New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the definition of each subject.

Your Cofactor profile
Sign up for an account to create your personal profile.